Ryan V Quiroz

5PUBLICATIONS
29CO-AUTHORS
GlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsMolecular medicineMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 30, 2026
Design of Novel Exatecan-Amide Linker-Payloads for the Development of Stable, Low-Aggregating, and Highly Efficacious Antibody-Drug Conjugates.

|Apr 30, 2026
Discovery of Novel N-Linked Camptothecin Linker-Payloads to Access Antibody-Drug Conjugates with High Target-Mediated In Vivo Efficacy.

|Mar 23, 2021
Development of a Flexible and Robust Synthesis of Tetrahydrofuro[3,4-b]furan Nucleoside Analogues.

David A Candito, Yingchun Ye, Ryan V Quiroz

|Mar 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer.

Ryan V Quiroz, Michael H Reutershan, Sebastian E Schneider

|Oct 14, 2017
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.

Paul A Wender, Clayton T Hardman, Stephen Ho

Pageof 1

Frequent Collaborators

2 joint publications

Rebecca E Johnson

2 joint publications

W Michael Seganish

2 joint publications

Fan Zhang

2 joint publications

Bernhard H Geierstanger